Cargando…
Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
BACKGROUND: Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties. One of these modifications is N-terminal pyroglutamate (pE) formation. Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x),...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850634/ https://www.ncbi.nlm.nih.gov/pubmed/24083638 http://dx.doi.org/10.1186/1471-2202-14-108 |
_version_ | 1782294132561018880 |
---|---|
author | Becker, Andreas Kohlmann, Stephanie Alexandru, Anca Jagla, Wolfgang Canneva, Fabio Bäuscher, Christoph Cynis, Holger Sedlmeier, Reinhard Graubner, Sigrid Schilling, Stephan Demuth, Hans-Ulrich von Hörsten, Stephan |
author_facet | Becker, Andreas Kohlmann, Stephanie Alexandru, Anca Jagla, Wolfgang Canneva, Fabio Bäuscher, Christoph Cynis, Holger Sedlmeier, Reinhard Graubner, Sigrid Schilling, Stephan Demuth, Hans-Ulrich von Hörsten, Stephan |
author_sort | Becker, Andreas |
collection | PubMed |
description | BACKGROUND: Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties. One of these modifications is N-terminal pyroglutamate (pE) formation. Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x), generating pE3-Aβ. Compared to unmodified Aβ, pE3-Aβ is more hydrophobic and neurotoxic. In addition, it accelerates aggregation of other Aβ species. To directly investigate pE3-Aβ formation and toxicity in vivo, transgenic (tg) ETNA (E at the truncated N-terminus of Aβ) mice expressing truncated human Aβ(3–42) were generated and comprehensively characterized. To further investigate the role of QC in pE3-Aβ formation in vivo, ETNA mice were intercrossed with tg mice overexpressing human QC (hQC) to generate double tg ETNA-hQC mice. RESULTS: Expression of truncated Aβ(3–42) was detected mainly in the lateral striatum of ETNA mice, leading to progressive accumulation of pE3-Aβ. This ultimately resulted in astrocytosis, loss of DARPP-32 immunoreactivity, and neuronal loss at the sites of pE3-Aβ formation. Neuropathology in ETNA mice was associated with behavioral alterations. In particular, hyperactivity and impaired acoustic sensorimotor gating were detected. Double tg ETNA-hQC mice showed similar Aβ levels and expression sites, while pE3-Aβ were significantly increased, entailing increased astrocytosis and neuronal loss. CONCLUSIONS: ETNA and ETNA-hQC mice represent novel mouse models for QC-mediated toxicity of truncated and pE-modified Aβ. Due to their significant striatal neurodegeneration these mice can also be used for analysis of striatal regulation of basal locomotor activity and sensorimotor gating, and possibly for DARPP-32-dependent neurophysiology and neuropathology. The spatio-temporal correlation of pE3-Aβ and neuropathology strongly argues for an important role of this Aβ species in neurodegenerative processes in these models. |
format | Online Article Text |
id | pubmed-3850634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38506342013-12-05 Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration Becker, Andreas Kohlmann, Stephanie Alexandru, Anca Jagla, Wolfgang Canneva, Fabio Bäuscher, Christoph Cynis, Holger Sedlmeier, Reinhard Graubner, Sigrid Schilling, Stephan Demuth, Hans-Ulrich von Hörsten, Stephan BMC Neurosci Research Article BACKGROUND: Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties. One of these modifications is N-terminal pyroglutamate (pE) formation. Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x), generating pE3-Aβ. Compared to unmodified Aβ, pE3-Aβ is more hydrophobic and neurotoxic. In addition, it accelerates aggregation of other Aβ species. To directly investigate pE3-Aβ formation and toxicity in vivo, transgenic (tg) ETNA (E at the truncated N-terminus of Aβ) mice expressing truncated human Aβ(3–42) were generated and comprehensively characterized. To further investigate the role of QC in pE3-Aβ formation in vivo, ETNA mice were intercrossed with tg mice overexpressing human QC (hQC) to generate double tg ETNA-hQC mice. RESULTS: Expression of truncated Aβ(3–42) was detected mainly in the lateral striatum of ETNA mice, leading to progressive accumulation of pE3-Aβ. This ultimately resulted in astrocytosis, loss of DARPP-32 immunoreactivity, and neuronal loss at the sites of pE3-Aβ formation. Neuropathology in ETNA mice was associated with behavioral alterations. In particular, hyperactivity and impaired acoustic sensorimotor gating were detected. Double tg ETNA-hQC mice showed similar Aβ levels and expression sites, while pE3-Aβ were significantly increased, entailing increased astrocytosis and neuronal loss. CONCLUSIONS: ETNA and ETNA-hQC mice represent novel mouse models for QC-mediated toxicity of truncated and pE-modified Aβ. Due to their significant striatal neurodegeneration these mice can also be used for analysis of striatal regulation of basal locomotor activity and sensorimotor gating, and possibly for DARPP-32-dependent neurophysiology and neuropathology. The spatio-temporal correlation of pE3-Aβ and neuropathology strongly argues for an important role of this Aβ species in neurodegenerative processes in these models. BioMed Central 2013-10-01 /pmc/articles/PMC3850634/ /pubmed/24083638 http://dx.doi.org/10.1186/1471-2202-14-108 Text en Copyright © 2013 Becker et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Becker, Andreas Kohlmann, Stephanie Alexandru, Anca Jagla, Wolfgang Canneva, Fabio Bäuscher, Christoph Cynis, Holger Sedlmeier, Reinhard Graubner, Sigrid Schilling, Stephan Demuth, Hans-Ulrich von Hörsten, Stephan Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration |
title | Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration |
title_full | Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration |
title_fullStr | Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration |
title_full_unstemmed | Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration |
title_short | Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration |
title_sort | glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850634/ https://www.ncbi.nlm.nih.gov/pubmed/24083638 http://dx.doi.org/10.1186/1471-2202-14-108 |
work_keys_str_mv | AT beckerandreas glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT kohlmannstephanie glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT alexandruanca glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT jaglawolfgang glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT cannevafabio glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT bauscherchristoph glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT cynisholger glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT sedlmeierreinhard glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT graubnersigrid glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT schillingstephan glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT demuthhansulrich glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration AT vonhorstenstephan glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration |